Perceived Consequences and Catastrophising Help Explain Health-Related Quality of Life in Parkinson’s Disease
Objective: To examine if illness representations and cognitive-behavioural responses to symptoms explain additional variance in health-related quality of life (HRQoL) beyond demographic and established clinical…International validation of the Neuropsychiatric Fluctuations Scale in patients with Parkinson’s disease
Objective: To evaluate the psychometric properties of the Neuropsychiatric Fluctuations Scale (NFS) in patients with Parkinson’s disease (PD) using classical test theory (CTT) and item-response…Impulse-compulsive disorders and non-motor symptom profiles in Parkinson’s disease: findings from a Tunisian cohort
Objective: To examine the relationship between impulse-compulsive disorders (ICDs) and non-motor symptom profiles in patients with Parkinson’s disease (PD). Background: ICDs are recognized non-motor complications…Prevalence of drooling in Parkinson’s disease: a multi-center observational study
Objective: This study investigated the prevalence of drooling and related factors. Background: The prevalence of drooling in Parkinson's disease (PD) varies widely, from 10% to…The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease
Objective: To investigate the impact of foslevodopa/foscarbidopa (LDp/CDp) on nonmotor symptoms (NMS) in adults with advanced Parkinson’s disease (aPD). Background: LDp/CDp, a 24-hour per day…The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease
Objective: This study aimed to evaluate how bilateral Globus Pallidus internus (GPi) Deep Brain Stimulation (DBS) affects non-motor symptoms in individuals diagnosed with Parkinson’s disease…Modification of Parkinson’s Disease Сourse Using Cell Technologies
Objective: To assess the long-term results of the introduction of autologous mesenchymal stem cells (MSCs) on the intensity of motor and non-motor symptoms and on…Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Objective: To assess the safety and effectiveness of GLP-1 RAs in patients with PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by…Non-Motor Fluctuations In Parkinson’s Disease: A Cross-Sectional Study On Prevalence, Correlates, And Impact On Quality Of Life
Objective: The study aims to assess the prevalence and characteristics of NMF in PD patients in Indian settings and explore their correlation with disease severity,…Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease
Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 63
- Next Page »